We now know how Carl Icahn's Herbalife sale fell through
Reuters
Icahn and Bill Ackman have had a long-running feud over Herbalife, the nutritional supplements company. Ackman is short the position, Icahn is long. Their battle came to a head earlier this summer, when the Wall Street Journal reported that Icahn was shopping around Herbalife shares.
Since then, Icahn has skirted around confirming the story, and as recently as last week, avoided a question on it during his interview at the Delivering Alpha hedge fund conference in New York.
The latest story by Fortune involves a Jefferies exec texting Ackman while he was vacationing in Italy to ask for a meeting to discuss a potential sale. Jefferies shopped the idea around to other investors, too, but the deal eventually fell through.
Here's Fortune:
"In the end, despite at least a month of scouring Wall Street, and hamstrung by legal restrictions (more on that later), the best bid Jefferies was able to get Icahn was for a little more than 11 million, of Icahn's 17 million, Herbalife shares at a price of $51.50 a share-about $10 south of where shares of Herbalife were trading on the open market at the time, sources familiar with the bid said. (People close to Jefferies put the figure a few dollars higher.) It didn't take Icahn long to reject the bid."
- People intolerant of other religions are more likely to reject science, study asserts
- 7 reasons why cucumber can be your summer weight loss friend
- 8 refreshing kulfis you must try this summer
- Adani Enterprises Q4 net falls 37%; incubating businesses show strong momentum
- India, New Zealand hold Joint Trade Committee meeting to deepen relations
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market